Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1
Clinical trial NCT04456049 · TERMINATED
Trial details
- NCT number
- NCT04456049
- Sponsor
- Ricardo Pereira Mestre
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-24
- Primary completion
- 2021-06-09
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.